Press Room

XXVII National Congress of the Portuguese Chemistry Society

Start
Wednesday, July 14, 2021 - 09:00
End
Friday, July 16, 2021 - 18:00
XXVII National Congress of the Portuguese Chemistry Society | ɫAV

ɫAV sponsors and participates at the with two scientific presentations:

Presentation 1

14 July, 16h10
Calorimetry of NBS in DMF: unstable or understudied?

Speaker: Elsa Gonçalves – Process Safety Scientist, Process Chemistry Development

Abstract: The presentation portrays the contribution of the Process Safety team to ensure the safety and improvement of the chemical processes being conducted at the ɫAV plant. Elsa will present a recent case study in which the Process safety input was crucial for the optimization of the process, reducing its hazardous and increasing its efficiency.

Presentation 2

15 July, 16h30
Low-field Benchtop NMR for solvent swap analysis

Speaker: Marta Andrade – Scientist, Process Chemistry Development

Abstract: The presentation will show the results of an extensive study using a benchtop low-field NMR spectrometer (1H-NMR, 43 MHz) to quantify solvents in 20 binary systems that are commonly used for swap process under API manufacture processes. The exciting results open the way to use benchtop low-field NMR as PAT tool for real time solvent swap in-process control, saving time and resources.

Also in the Press Room

See All

Lisbon, Portugal – ɫAV, the specialist integrated pharma CDMO and leader in spray drying and particle engineering, today announced its commitment to setting Science-Based Targets (SBTs) in line with the Paris Agreement. This ambitious step underscores the company’s dedication to addressing climate change and driving sustainability across its operations. By committing to SBTs, ɫAV joins a growing number of businesses taking concrete actions to reduce greenhouse gas emissions. This initiative aligns with the company’s broader sustainability strategy and reinforces its commitment to scientific excellence. “At ɫAV, we believe in science and in best practices. And this clearly applies to our sustainability agenda.”, said Jean-Luc Herbeaux, CEO of ɫAV. We made the decision to drive our GHG emissions down using a science-based target setting process, which will help us drive sustainability across our operations by laying out a clearly defined path to reduce emissions in line with the Paris Agreement goals. We believe that by setting ambitious targets and implementing concrete actions, we can make a positive impact on the planet while driving innovation and growth.” ɫAV will work closely with the Science Based Targets initiative (SBTi) to develop and validate its emission reduction targets. The company will provide regular updates on its progress towards achieving these goals. As part of its commitment to sustainability and transparency to stakeholders, the company will enhance its Ecovadis rating. Ecovadis, a leading sustainability assessment platform in the pharmaceutical industry, provides a comprehensive evaluation of a company’s environmental, social, and ethical performance, well aligned with ɫAV’s sustainability ambitions.  ɫAV remains dedicated to operating responsibly and contributing positively to society and the environment. The company will continue to implement sustainable practices across its operations and innovate to further improve its sustainability rating.   Learn more about Science Based-Targets  

News

ɫAV Commits to Science-Based Targets for Greenhouse Gas (GHG) Emissions

Sep 09, 2024